Psoriasis:
Indications for: IMPOYZ
Moderate to severe plaque psoriasis.
Adult Dosage:
≥18yrs: apply thin layer twice daily; max 50g/week and 2 consecutive weeks' treatment per course. Discontinue when control is achieved. Wash hands after application. Do not occlude.
Children Dosage:
<18yrs: not recommended.
IMPOYZ Warnings/Precautions:
Avoid use on face, scalp, axilla, groin, or other intertriginous areas. Do not use for diaper dermatitis or on pre-existing skin atrophy. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, use of occlusive dressings, altered skin barrier, liver failure, young age; discontinue gradually, reduce dose, or substitute with less potent corticosteroid if occurs. Treat infection if present; discontinue if infection persists or worsens. Avoid abrupt cessation in chronic use. Reevaluate periodically. Pregnancy. Nursing mothers.
IMPOYZ Classification:
Corticosteroid.
Adverse Reactions:
Application site discoloration, burning, itching, irritation, dryness, folliculitis, acneiform eruptions, hypertrichosis, hypopigmentation, perioral dermatitis, allergic contact dermatitis (discontinue if irritation occurs), secondary infection, striae, miliaria; HPA axis suppression (esp. in children); rare: Cushing's syndrome, hyperglycemia, glucosuria.
Generic Drug Availability:
NO
How Supplied:
Crm—60g
